Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer.

Buck, Emanuel

Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer. [electronic resource] - Oncology letters Apr 2019 - 3890-3898 p. digital

Publication Type: Journal Article

ISSN: 1792-1074

Standard No.: 10.3892/ol.2019.10043 doi

Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer.

APA

Buck E., Sprick M., Gaida M. M., Grüllich C., Weber T. F., Herpel E., Bruckner T. & Koschny R. (2019). Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer. : Oncology letters.

Chicago

Buck Emanuel, Sprick Martin, Gaida Matthias M, Grüllich Carsten, Weber Tim Frederik, Herpel Esther, Bruckner Thomas and Koschny Ronald. 2019. Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer. : Oncology letters.

Harvard

Buck E., Sprick M., Gaida M. M., Grüllich C., Weber T. F., Herpel E., Bruckner T. and Koschny R. (2019). Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer. : Oncology letters.

MLA

Buck Emanuel, Sprick Martin, Gaida Matthias M, Grüllich Carsten, Weber Tim Frederik, Herpel Esther, Bruckner Thomas and Koschny Ronald. Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer. : Oncology letters. 2019.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC